Back | Next |
home / stock / bior / bior message board
Subject | By | Source | When |
---|---|---|---|
Hodling | masterofdisaster | investorshub | 01/18/2023 12:07:46 AM |
My number 1 squeeze potential stock here | masterofdisaster | investorshub | 01/17/2023 3:59:08 PM |
CTB now 261% | masterofdisaster | investorshub | 01/16/2023 9:48:54 PM |
CTB now 224% | masterofdisaster | investorshub | 01/16/2023 4:54:41 PM |
CTB now 206.9% | masterofdisaster | investorshub | 01/15/2023 3:06:48 AM |
Loaded the dip 2 times over | harry crumb | investorshub | 01/13/2023 9:58:53 PM |
CTB 176% now.....buying the dip | masterofdisaster | investorshub | 01/13/2023 7:18:40 PM |
The order flow showed more buying then selling | masterofdisaster | investorshub | 01/13/2023 12:42:09 PM |
Volume will kick back in any day. Holding | masterofdisaster | investorshub | 01/13/2023 12:39:59 PM |
Yes sir agree 100%, most bios constantly dilute, | harry crumb | investorshub | 01/13/2023 2:36:18 AM |
I gotcha, understood. But il make wealth on | harry crumb | investorshub | 01/13/2023 2:34:32 AM |
https://fintel.io/ss/us/bior | masterofdisaster | investorshub | 01/13/2023 2:07:59 AM |
This stock has been a diluting POS for | masterofdisaster | investorshub | 01/13/2023 1:59:35 AM |
Cost to borrow | masterofdisaster | investorshub | 01/13/2023 1:42:20 AM |
Ctb? | harry crumb | investorshub | 01/13/2023 12:45:21 AM |
Looking at AH there is still selling, this | harry crumb | investorshub | 01/13/2023 12:43:38 AM |
CTB just jumped from 13% to 115% with | masterofdisaster | investorshub | 01/13/2023 12:28:22 AM |
$BIOR is about to go parabolic | masterofdisaster | investorshub | 01/13/2023 12:25:40 AM |
Is Biora Therapeutics (PROG) Stock About to Go Big? | AstronautApe_888 | investorshub | 01/12/2023 4:51:23 AM |
That pop after the halt was a sweet one | harry crumb | investorshub | 01/12/2023 1:29:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Biora Therapeutics Inc. Company Name:
BIOR Stock Symbol:
NASDAQ Market:
Biora Therapeutics Inc. Website:
Pharmacokinetic and tissue data confirm NaviCap platform delivers topically through the entire colon, with lower systemic concentrations, as desired Data modeling suggests tofacitinib tissue concentrations greater than IC90 through at least 16 hours after dosing SAN DIEGO, July 18...
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced further details on its virtual event to be held on Wednesday, July 17, 2024. The event will feature Bruce Sands, MD, MS (Icahn School of ...
Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ab...